Erythrocyte Membrane Biomimetic Boron Nitride Nanospheres as Carrier for the Delivery of Antitumor Drug
CSTR:
Author:
Affiliation:

Clc Number:

R945

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    In this work,red blood cell(RBC) membrane coating technique was used to camouflage inorganic BNNS,thus forming biomimetic RBC-membrane-coated BNNS(RBC-BNNS) drug delivery system. The functionalization of BNNS with RBC-membrane was characterized by transmission electron microscopy(TEM),particle size and zeta potential analysis. Besides,the influence of RBC-membrane modification to the drug loading capacity was also analyzed with doxorubicin(DOX) as model drug. Then,the human cervical carcinoma cell line HeLa cells was selected as model cancer cells to investigate the biocompatibility of RBC-BNNS and the cellular uptake and antitumor effect of DOX@RBC-BNNS.

    Reference
    Related
    Cited by
Get Citation

FENG Shini, ZHANG Huijie, GAO Xiaodong, NAKANISHI Hideki. Erythrocyte Membrane Biomimetic Boron Nitride Nanospheres as Carrier for the Delivery of Antitumor Drug[J]. Journal of Food Science and Biotechnology,2019,38(9):72-77.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: March 31,2020
  • Published:
Article QR Code

Copy Right:Editorial Board of Journal of Food Science and Biotechnology

Address:No. 1800, Lihu Avenue, Wuxi 214122, Jiangsu Province,China  PostCode:214122

Phone:0510-85913526  E-mail:xbbjb@jiangnan.edu.cn

Supported by:Beijing E-Tiller Technology Development Co., Ltd.

WeChat

Mobile website